How big is Nektar Therapeutics?

Jun 22 2025 05:37 PM IST
share
Share Via
As of Jun 18, Nektar Therapeutics has a market capitalization of 108.31 million and reported net sales of 87.25 million with a net profit of -133.04 million over the latest four quarters. Shareholder's funds are 60.74 million, and total assets amount to 303.85 million.
As of Jun 18, Nektar Therapeutics has a market capitalization of 108.31 million, classifying it as a Micro Cap company.

As of Jun 18, the sum of net sales for the latest four quarters is 87.25 million, while the sum of net profit for the same period is -133.04 million.

As of Dec 24, the shareholder's funds are reported at 60.74 million, and total assets amount to 303.85 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News